CABG better than PCI in diabetes patients on insulin, study finds

11/1/2013 | Medscape (free registration)

Diabetes patients with multivessel disease who underwent coronary artery bypass graft surgery had lower rates of all-cause mortality, nonfatal myocardial infarction or nonfatal stroke than those who underwent percutaneous coronary intervention, according to a review presented at the Transcatheter Cardiovascular Therapeutics meeting. Researchers also found that both insulin-dependent and non-insulin-dependent patients who had CABG showed lower rates of major adverse cardiovascular events at five years compared with the PCI arm.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD